The epidemic challenge of chronic kidney disease in older patients

Postgraduate Medicine

Volumn 120, Issue 4, 2008, Pages 87-94

  Abdelhafiz, Ahmed H ^a   Tan, Evelyn ^a   El Nahas, Meguid ^b  

^a ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Chronic kidney disease; Elderly patients; Glomerular filtration rate; Management; Prognosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN;

ANEMIA; CHRONIC KIDNEY DISEASE; CLINICAL DECISION MAKING; DIAGNOSTIC PROCEDURE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY TRANSPLANTATION; OUTCOME ASSESSMENT; PATIENT REFERRAL; RENAL REPLACEMENT THERAPY; REVIEW; AGE; AGED; CHRONIC DISEASE; EPIDEMIC; KIDNEY DISEASE; MIDDLE AGED;

AGE FACTORS; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DISEASE OUTBREAKS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MIDDLE AGED;

EID: 58149187287     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2008.11.1943     Document Type: Review

References (63)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:(2 suppl 1):S1-S266.
2. Davison AM. Renal disease in the elderly. Nephron. 1998;80(1):6-16.
3. Jungers P, Chauveau P, Descamps-Latscha B, et al. Age and gender-related incidence of chronic renal failure in a French urban area: a prospective epidemiologic study. Nephrol Dial Transplant. 1996;11(8):1542-1546.
4. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41(1):1-12.
5. Xue JL, Ma JZ, Louis TA, et al. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol. 2001;12(12):2753-2758.
6. UK Renal Registry. UK Renal Registry Report 2007. www.renalreg.com. Accessed October 24, 2008.
7. Krishnan M, Lok CE, Jassal SV. Epidemiology and demographic aspects of treated end-stage renal disease in the elderly. Semin Dial. 2002;15(2):79-83.
8. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33(4):278-285.
9. Abreu PF, Ramos LR, Sesso R. Abnormalities of renal function in the elderly. Geriatr Nephrol Urol. 1999;9(3):141-145.
10. Henry RM, Kostense P, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int. 2002;62(4):1402.
11. Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M; Cholesterol and Recurrent Events (CARE) Trial Investigators. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ. 2006;332(7555):1426.
12. Kurella M, Chertow GM, Fried LF, et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol. 2005;16(7):2127-2133.
13. Fried LF, Lee JS, Shlipak M, et al. Chronic kidney disease and functional limitation in older people: health, aging and body composition study. J Am Geriatr Soc. 2006;54(5):750-756.
14. Ensrud KE, Lui LY, Taylor BC, et al; Osteoporotic Fractures Research Group. Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med. 2007;167(2):133-139.
15. Prakash J, Saxena RK, Sharma OP, Usha. Spectrum of renal diseases in the elderly: single center experience from a developing country. Int Urol Nephrol. 2001;33(2):227-233.
16. Arora P, Mustafa RA, Karam J, et al. Care of elderly patients with chronic kidney disease. Int Urol Nephrol. 2006;38:363-370.
17. Selvarajah V, Isles C. End-stage renal disease in the very elderly. J R Coll Physicians Edinb. 2007;37:141-146.
18. United States Renal Data System. USRDS 2003 Annual Data Report: Atlas of end stage renal disease in the United States. National Institute of Diabetes and Digestive and Kidney Diseases; 2003.
19. Drey N, Roderick P, Mullee M, et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis. 2003;42(4):667-684.
20. Swedko PJ, Clark HD, Paramsothy K, et al. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med. 2003;163(3):356-360.
21. Martin A, Mellotte G, O'Neill D. Chronic kidney disease in the elderly; a silent epidemic. Irish Med J. 2005;98(2):46-47.
22. Ouseph R, Hendricks P, Hollon JA, Bhimani BD, Lederer ED. Underrecognition of chronic kidney disease in elderly outpatients. Clin Nephrol. 2007;68(6):373-378.
23. Quartarolo JM, Thoelke M, Schafers SJ. Reporting of estimated glomerular filtration rate: effect on physician recognition of chronic kidney disease and prescribing practices for elderly hospitalized patients. J Hosp Med. 2007;2(2):74-78.
24. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation Practice Guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137-147.
25. Hallan S, Astor B, Lydersen S. Estimating glomerular filtration rate in the general population: the second Health Survey of Nord-Trondelag (HUNT II). Nephrol Dial Transplant. 2006;21(6):1525-1533.
26. Lamb EJ, Webb MC, Simpson DE, et al. Estimation of glomerular filtration rate in older patients with chronic renal insufficiency: Is the modification of diet in renal disease formula an improvement? J Am Geriatr Soc. 2003;51(7):1012-1017.
27. Rigalleau V, Lasseur C, Raffaitin C, et al. Diagnosis of chronic kidney disease in elderly subjects with diabetes mellitus. J Am Geriatr Soc. 2006;54(6):1007-1008.
28. Grubb AO. Cystatin C - properties and use as diagnostic marker. Adv Clin Chem. 2000;35:63-99.
29. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005; 352(20):2049-2060.
30. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003;18(10):2024-2031.
31. Hemmelgarn BR, Zhang J, Manns BJ, et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int. 2006;69(12):2155- 2161.
32. Young JH, Klag MJ, Muntner P, Whyte JL, Pahor M, Coresh J. Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol. 2002;13(11):2776-2782.
33. Bleyer AJ, Shemanski LR, Burke GL, et al. Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. Kidney Int. 2000;57(5):2072-2079.
34. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164(6):659-663.
35. O'Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18(10):2758-2765.
36. Hallan SI, Dahl K, Oien CM, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2006;333(7577):1047-1053.
37. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention. Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
38. Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy. Lancet. 1998;352(9136):1252-1256.
39. Siebenhofer A, Plank J, Horvath K, et al. Angiotensin receptor blockers as anti-hypertensive treatment for patients with diabetes mellitus: meta-analysis of controlled double-blind randomised trials. Diabet Med. 2004;21(1):18-25.
40. Mogensen CE, Neldam S, Tikkanen I, et al. Randomised controlled trial of dual blockade of the renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ. 2000;321(7274):1440-1444.
41. Palmer BF. Renal dysfunction complicating the treatment of hypertension. N Engl J Med. 2002;347(16):1256-1261.
42. Martin U, Coleman JJ. Monitoring renal function in hypertension BMJ. 2006;333(7574):896-899.
43. Mulec H, Blohme G, Grande B, Björck S. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt nephropathy. Nephrol Dial Transplant. 1998;13(3):651-655.
44. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int. 2001;59(1):260-269.
45. Jurkovitz CT, Abramson JL, Vaccarino LV, Weintraub WS, McClellan WM. Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol. 2003;14(11):2919-2925.
46. Portoles J, Torralbo A, Martin P, Rodrigo J, Herrero JA, Barrientos A. Cardiovascular effects of recombinant human erythropoietin in predialysis patients. Am J Kidney Dis. 1997;29(4):541-548.
47. Lefebvre P, Duh MS, Buleau S, et al. Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease. J Am Soc Nephrol. 2006;17(12):3497-3502.
48. Fink J, Blahut S, Reddy M, Light P. Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis. 2001;37(2):348-355.
49. Ho LT, Sprague SM. Renal osteodystrophy in chronic renal failure. Semin Nephrol. 2002;22(6):488-493.
50. Hemmelgarn BR, Manns BJ, Zhang J, et al. Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol. 2007;18(3):993-999.
51. Winkelmayer WC, Glynn RJ, Levin R, Owen WF Jr, Avorn J. Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis. 2001;38(6):1178-1184.
52. John R, Webb M, Young A, Stevens PE. Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis. 2004;43(5):825-835.
53. Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 2002;61(1):305-316.
54. Rayner HC, Besarab A, Brown WW, et al. Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Ouality Initiative (K/DOQI) Clinical Practice Guidelines. Am J Kidney Dis. 2004;44(5 suppl 3):22-26.
55. Joly D, Anglicheau D, Alberti C, et al. Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol. 2003;14(4):1012-1021.
56. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant. 2007;22(7):1955-1962.
57. Kurella M, Covinsky KE, Collins AJ, Chertow GM. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med. 2007;146(3):177-183.
58. Rao PS, Merion RM, Ashby VB, Port EK, Wolfe RA, Kayler LK. Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation. 2007;83(8):1069-1074.
59. Brunori G, Viola BF, Parrinello G, et al. Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: A prospective randomized multicenter controlled study. Am J Kidney Dis. 2007;49(5):569-580.
60. Renal Physicians Association and American Society of Nephrology Clinical Practice Guideline. Shared Decision-Making in the Appropriate Initiation and Withdrawal from Dialysis. Report No. 2. Washington, DC; 2000.
61. Li M, Porter E, Lam R, Jassal SV. Quality improvement through the introduction of interdisciplinary geriatric hemodialysis rehabilitation care. Am J Kidney Dis. 2007;50(1):90-97.
62. Hackett AS, Watnick SG. Withdrawal from dialysis in end-stage renal disease: medical, social, and psychological issues. Semin Dial. 2007;20(1):86-90.
63. Kuczewski MG. Our cultures, our selves: toward an honest dialogue on race and end of life decisions. Am J Bioeth. 2006;6(5):13-17.